You are here: Industry Insights > Market News > Pharma exports up 12.43 per cent during Apr-Dec 2021

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Brexpiprazole Intermediate CAS:70500-72-0

Brexpiprazole CAS:913611-97-9

3-BROMOPHENANTHRENE

2-FLUORO-4-(TRIFLUOROMETHYL)BENZOPHENONE

3-BROMO-4-FLUOROBIPHENYL

9-TRIFLUOROACETYLANTHRACENE

Pharma exports up 12.43 per cent during Apr-Dec 2021

expresspharmaFebruary 08, 2021

Tag: India , Export

Favorites

India’s exports of pharmaceutical products during April-December 2020-21 grew by 12.43 per cent to USD 17.57 billion.

India’s exports of pharma products have not declined and they are growing consistently, Minister of State for Commerce and Industry Hardeep Singh Puri said in a written reply to the Rajya Sabha.

“During 2019-20, India’s exports of pharma were USD 20.58 billion with a growth rate of 7.57 per cent over the previous year. Total pharma exports during April-December 2020-21 were at USD 17.57 billion, registering a growth rate of 12.43 per cent over the same period of the previous year,” he said.

Previous:AstraZeneca expects US trial results in next 4-6 weeks, research chief says

Next:India sent 56 L COVID-19 vaccines to foreign nations as gift;100 L doses as commercial supplies: MEA

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Pharma exports up 12.43 per cent during Apr-Dec 2021 | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Customized blister box food inner tray Customized export blister tray PVC plastic box Plastic tray

Import and Export Service of Pharmaceutical Reagents, Chemicals, and Batteries

Wellgreen Low Price Export Iso Certified Tannic acid Food Grade Gallic Acid Galla Chinensis Extract

Best castor oil with competitive price from China by manufactuer for export

Celery Seeds Seed Export Extract White Fresh Dried Price Chinese Root Extracts Celery Powder

100% Pure Freeze Dried Black Berry Anthocyanin Juice Indian Instant Fruit Blackberry Powder

Import and export of dangerous goods by sea

Mifepristone (INDIA DMF)

China Low Price Herbal Factory Direct Export Semen Fragrans Myristicae Powder Nutmeg Extract

Wellgreen Factory Direct Export Food Grade Health Care Use Fennel Seeds Extract Powder

Pharma exports up 12.43 per cent during Apr-Dec 2021

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>